baicalin has been researched along with Respiratory Syncytial Virus Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Huang, X; Qin, S; Qu, S | 1 |
Cheng, K; Gao, B; Wu, Z; Xu, J | 1 |
Li, E; Lv, B; Ren, K; Shi, H; Tan, RX; Zhang, W; Zhao, Y | 1 |
3 other study(ies) available for baicalin and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Baicalin Induces a Potent Innate Immune Response to Inhibit Respiratory Syncytial Virus Replication
Topics: Animals; Child; Flavonoids; Humans; Immunity, Innate; Mice; Molecular Docking Simulation; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; RNA | 2022 |
Analysis of influence of baicalin joint resveratrol retention enema on the TNF-α, SIgA, IL-2, IFN-γ of rats with respiratory syncytial virus infection.
Topics: Animals; Antiviral Agents; Cell Line; Drug Interactions; Enema; Female; Flavonoids; Humans; Immunoglobulin A, Secretory; Interferon-gamma; Interleukin-2; Male; Rats; Rats, Sprague-Dawley; Respiratory Syncytial Virus Infections; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2014 |
Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.
Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Cell Survival; Disease Models, Animal; Female; Flavonoids; Humans; Lung Injury; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Scutellaria baicalensis; Virus Internalization; Virus Replication | 2016 |